4961 - 4970 of 6516 Results
Title
Year
- Aggressiveness after centromedian nucleus stimulation engages prefrontal thalamocortical circuitry2019OPENTitle: Aggressiveness after centromedian nucleus stimulation engages prefrontal thalamocortical circuitryJournal Name: Brain StimulationPublisher: Elsevier BVVol: 13Issue #: 2Start Page: 357End Page: 359Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brs.2019.10.023Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X19304346/pdfCitation Count: 18
-
OPENTitle: Human plasma biomarker responses to inhalational general anaesthesia without surgeryJournal Name: British Journal of AnaesthesiaPublisher: Elsevier BVVol: 125Issue #: 3Start Page: 282End Page: 290Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.bja.2020.04.085Best OA location URL: http://www.bjanaesthesia.org/article/S0007091220303391/pdfCitation Count: 52
-
OPENTitle: Neural closed-loop deep brain stimulation for freezing of gaitJournal Name: Brain StimulationPublisher: Elsevier BVVol: 13Issue #: 5Start Page: 1320End Page: 1322Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2020.06.018Best OA location URL: http://www.brainstimjrnl.com/article/S1935861X20301364/pdfCitation Count: 59
- Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate?2020OPENTitle: Do Parkinson disease subject and caregiver-reported Epworth sleepiness scale reponses correlate?Journal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 192Issue #:Start Page: 105728End Page: 105728Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2020.105728Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7183413Citation Count: 2
-
OPENTitle: Personalized care management for persons with Parkinson's disease: A telenursing solutionJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 3Issue #:Start Page: 100070End Page: 100070Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100070Best OA location URL: https://doi.org/10.1016/j.prdoa.2020.100070Citation Count: 11
-
OPENTitle: Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patientsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 3Issue #:Start Page: 100042End Page: 100042Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2020.100042Best OA location URL: https://doi.org/10.1016/j.prdoa.2020.100042Citation Count: 9
-
OPENTitle: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline SummaryJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 20Start Page: 942End Page: 957Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868Best OA location URL: https://n.neurology.org/content/neurology/97/20/942.full.pdfCitation Count: 173
-
OPENTitle: Data Sharing Goals for Nonprofit Funders of Clinical TrialsJournal Name: Journal of Participatory MedicinePublisher: JMIR Publications Inc.Vol: 13Issue #: 1Start Page: e23011End Page: e23011Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/23011Best OA location URL: https://jopm.jmir.org/2021/1/e23011/PDFCitation Count: 4
-
OPENTitle: LRRK2-phosphorylated Rab10 sequesters Myosin Va with RILPL2 during ciliogenesis blockadeJournal Name: Life Science AlliancePublisher: Life Science Alliance, LLCVol: 4Issue #: 5Start Page: e202101050End Page: e202101050Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.26508/lsa.202101050Best OA location URL: https://www.life-science-alliance.org/content/lsa/4/5/e202101050.full.pdfCitation Count: 54
-
OPENTitle: Pilot Study to Evaluate Pimavanserin for the Treatment of Motor and Behavioral Symptoms of Tourette SyndromeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 5Start Page: 694End Page: 700Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13207Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8287163Citation Count: 10